Trade Mark Journal No.2026/018 1 May 2026

UK00004371444 10 April 2026 (5)

WONDURSA

International priority date claimed: 18 December 2025 (Ireland) (202503214)

Class 5: Pharmaceutical preparations for the treatment and prevention of HIV infection; Pharmaceutical preparations for the treatment of viral infection, fungal infection, fibrosis, liver diseases and disorders, hepatitis, hematological diseases and disorders, oncological diseases and disorders, inflammatory diseases and disorders, autoimmune diseases and disorders, respiratory and pulmonary diseases and disorders, kidney and nephrotic diseases and disorders, arthritis, obesity, metabolic diseases and disorders, endocrine diseases and disorders, and gastrointestinal diseases and disorders.

Gilead Sciences Ireland UC

Representative: Aneta Stawska